Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%
Clinical trial NCT02752646 · COMPLETED
Trial details
- NCT number
- NCT02752646
- Sponsor
- MDbackline, LLC
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2017-03-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.